Sleep Disturbances in Lung Cancer Patients Assigned to Definitive or Adjuvant Irradiation

Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..

BACKGROUND/AIM: A considerable number of patients with lung cancer are scheduled for definitive or adjuvant radiotherapy. Prevalence and potential risk factors of pre-radiotherapy sleep disturbances were evaluated.

PATIENTS AND METHODS: Nineteen factors were retrospectively investigated for associations with pre-radiotherapy sleep disturbances in 77 lung cancer patients. Factors included COVID-19 pandemic; age; gender; performance score; comorbidity index; history of another malignancy; distress score; number of emotional, physical or practical problems; patient's request for psychological support; histology; tumor stage; upfront surgery; chemotherapy; and type of radiotherapy.

RESULTS: Thirty-one patients (40.3%) reported sleep disturbances that were significantly associated with distress score 6-10 (p=0.019), ≥2 emotional problems (p=0.001), ≥5 physical problems (p<0.001), and request for psychological support (p=0.006). Trends were found for female gender (p=0.064) and stereotactic body radiation therapy (p=0.057).

CONCLUSION: Many lung cancer patients assigned to radiotherapy reported sleep disturbances. Risk factors can be used to identify patients in need of psychological support already before treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

In vivo (Athens, Greece) - 35(2021), 6 vom: 25. Nov., Seite 3333-3337

Sprache:

Englisch

Beteiligte Personen:

Rades, Dirk [VerfasserIn]
Kopelke, Svenja [VerfasserIn]
Tvilsted, Soeren [VerfasserIn]
Kjaer, Troels W [VerfasserIn]
Schild, Steven E [VerfasserIn]
Bartscht, Tobias [VerfasserIn]

Links:

Volltext

Themen:

Frequency
Irradiation
Journal Article
Lung cancer patients
Risk factors
Sleep disturbances

Anmerkungen:

Date Completed 27.10.2021

Date Revised 14.12.2021

published: Print

Citation Status MEDLINE

doi:

10.21873/invivo.12630

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332372413